How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?
about
Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in TaiwanThe role of adjuvant immunomodulatory agents for treatment of severe influenza.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study.
P2860
How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How Did Multiple FDA Actions A ...... zolidinediones in US Medicaid?
@en
How Did Multiple FDA Actions A ...... zolidinediones in US Medicaid?
@nl
type
label
How Did Multiple FDA Actions A ...... zolidinediones in US Medicaid?
@en
How Did Multiple FDA Actions A ...... zolidinediones in US Medicaid?
@nl
prefLabel
How Did Multiple FDA Actions A ...... zolidinediones in US Medicaid?
@en
How Did Multiple FDA Actions A ...... zolidinediones in US Medicaid?
@nl
P2093
P2860
P1476
How Did Multiple FDA Actions A ...... zolidinediones in US Medicaid?
@en
P2093
Anita K Wagner
Christine Y Lu
Fang Zhang
Jason C Hsu
P2860
P304
1420-1432.e1
P356
10.1016/J.CLINTHERA.2015.04.006
P577
2015-05-11T00:00:00Z